KTTA Analyst Ratings 2026

Pasithea Therapeutics Corp - Wall Street recommendations & price targets

Consensus Rating

N/A

Current Price

$0.74

Get Complete KTTA Analysis

AI insights, DCF valuation, and institutional ownership

View Full Analysis

Frequently Asked Questions

What is the analyst rating for KTTA?

Analyst rating data for KTTA is being updated. Check back for the latest Wall Street recommendations.

What is the KTTA price target?

Price target data for KTTA is being updated.

Is KTTA a buy according to analysts?

Check the latest analyst recommendations for KTTA.

How many analysts cover KTTA?

Analyst coverage information for KTTA is being updated.

Explore Categories